에서 실시간으로 운영 중이에요! 자세히 알아보기

Solesence Inc

SLSN

시가총액 US$6358만

0.9000 USD

+0.0117

1.32%

장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT

프리마켓

시간외 거래

0.8563

-0.0437

4.86%

1일

1.32%

5일

-11.76%

1개월

2.26%

3개월

15.34%

6개월

-25.62%

연초 이후

-40%

1년

-76.98%

5년

-49.72%

10년

-49.72%

소개: Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products. Additionally, it continues to sell products in legacy markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. The company operates as a single business segment.

직원 수: 115

필수소비재 가정용품 및 개인용품

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 0%

중립 100%

부정적 0%

Zacks Investment Research

SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt

Solesence's Q2 results are pressured by higher operating expenses, but improving production efficiency and expectations for a stronger second half provide reasons for optimism.

SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

Solésence Reports Second Quarter 2026 Financial Results

Please call Alissa Nakamoto at 216-509-9062 to confirm the details of the release. Please ensure that the release has the same distributions as past PRs.

Solésence Reports Second Quarter 2026 Financial Results

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date.

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

Zacks Investment Research

SLSN Unveils Two Scalp Care Products Using Patented Technology

Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.

SLSN Unveils Two Scalp Care Products Using Patented Technology

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

Zacks Investment Research

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin improves and the company reaffirms its 2026 profitability targets.

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation.

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.